Huntington Ingalls Industries, Inc.
—- Market cap
- $11.10B
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: HII stock price at discount vs LLY $281.67 current versus $753.07 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LLY's multiple
Implied fair value · at HII's multiple
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Lower P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 96% equity / 4% debt · EV / Revenue 16.76x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
HUNTINGTON INGALLS INDUSTRIES, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ELI LILLY AND COMPANY · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
GENERAL DYNAMICS CORP
HII vs GD
LOCKHEED MARTIN CORP
HII vs LMT
NORTHROP GRUMMAN CORP /DE/
HII vs NOC
TEXTRON INC
HII vs TXT
Howmet Aerospace Inc.
HII vs HWM
AXON ENTERPRISE, INC.
HII vs AXON
Pfizer Inc.
HII vs PFE
Merck & Co., Inc.
HII vs MRK
Johnson & Johnson
HII vs JNJ
AbbVie Inc.
HII vs ABBV
Amgen Inc.
HII vs AMGN
Bristol-Myers Squibb Company
HII vs BMY
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe HII can materially re-rate toward a higher growth and margin profile without a DCF-based value reset, then a selective long position could make sense because the stock is cheap on P/E and P/S versus LLY; otherwise, the data support a neutral stance since HII’s own historical trading band and DCF range do not confirm the headline upside.
HII trades at 21.2x P/E and 1.0x P/S versus LLY at 48.9x P/E and 16.2x P/S, so the market is assigning LLY a much richer growth and quality premium. On the provided P/E-based framework, HII’s implied price is $751.97 versus a current price of $325.95, implying 130.7% upside, but that valuation gap is not mirrored by the operating profile.
Supporting Metrics